INS and diabetes mellitus: Thus, the attenuation of diabetes-induced changes in SL activities by both sarpogrelate and insulin treatments may be associated with the beneficial effects of these interventions on myocardial metabolism, cardiac function and cardiac ultrastructure as a consequence of preventing the occurrence of intracellular Ca2+ overload.